Clinical Trials Browser

Phase 1 × Rifampin × Plasma cell × Clear all

NCT00608907 2012-01-30

An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib)

Phase 1 Completed

61 enrolled 9 charts

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma